Glass House Brands (GLAS) Retained Earnings (2020 - 2026)

Glass House Brands' (GLAS) quarterly Retained Earnings came in at -$237.2 million in Q1 2026, down 18.32% year-on-year from -$290.4 million in Q1 2025, and down 7.78% on a QoQ basis from -$220.1 million in Q4 2025.

Glass House Brands (GLAS) Retained Earnings (2020 - 2026) Analysis & Trends

Glass House Brands (GLAS) has 7 years of Retained Earnings data on file, last reported at -$237.2 million in Q1 2026.

  • On a quarterly basis, Retained Earnings fell 18.32% year-over-year to -$237.2 million in Q1 2026; TTM through Mar 2026 was -$237.2 million, a 18.32% decrease from a year earlier, with the FY2025 full-year figure at -$220.1 million, down 15.58% from the prior year.
  • Retained Earnings for Q1 2026 stood at -$237.2 million, down from -$220.1 million in the prior quarter.
  • Over the last five years, Retained Earnings for GLAS reached as high as -$79.6 million in Q3 2022 and fell as low as -$237.2 million in Q1 2026.
  • Historically, Retained Earnings has averaged -$167.6 million across 5 years, with a median of -$190.9 million in 2023.
  • Across the five-year window, Retained Earnings slumped 1243.84% in 2022 and advanced 4.2% in 2025, its largest moves.
  • Year by year, Retained Earnings stood at -$92.7 million in 2022, then slumped by 106.05% to -$190.9 million in 2023, then grew by 0.27% to -$190.4 million in 2024, then decreased by 15.58% to -$220.1 million in 2025, then declined by 7.78% to -$237.2 million in 2026.
  • Per Business Quant data, the three most recent Retained Earnings figures were -$237.2 million in Q1 2026, -$220.1 million in Q4 2025, and -$204.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - 37.04 Bn
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 28.20 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 1.11 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 4.54 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 8.83 Bn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -413.76 Mn
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 18.66 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 589.60 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -2.13 Bn
10 Glass House Brands 873.84 Mn 845.91 Mn 10.02 Mn -237.21 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -237.21 Mn
Dec 31, 2025 -220.08 Mn
Sep 30, 2025 -204.10 Mn
Jun 30, 2025 -191.81 Mn
Mar 31, 2025 -200.48 Mn
Dec 31, 2024 -190.42 Mn
Sep 30, 2024 -202.52 Mn
Jun 30, 2024 -199.27 Mn
Mar 31, 2024 -209.27 Mn
Dec 31, 2023 -190.94 Mn
Sep 30, 2023 -160.37 Mn
Jun 30, 2023 -160.10 Mn
Mar 31, 2023 -135.09 Mn
Dec 31, 2022 -92.67 Mn
Sep 30, 2022 -79.62 Mn
Jun 30, 2022 -94.80 Mn
Mar 31, 2022 -80.63 Mn
Dec 31, 2021 -59.76 Mn
Sep 30, 2021 -42.26 Mn
Mar 31, 2021 -6.00 Mn